Neuphoria Therapeutics shares closed up in their first Nasdaq trading day after Bionomics re-domiciled to the U.S. from Australia and Neuphoria became the ultimate parent company of Bionomics. The ...

Bionomics ( ) has issued an update. Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring governance from Bionomics’ organizational documents to Neuphorias ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to ...

Neuphoria Therapeutics Inc., a Delaware corporation, has successfully completed the redomiciliation process of Bionomics Limited, an Australian corporation, on December 23, 2024. This transformative ...

Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”) is pleased to announce that its previously announced scheme of arrangement ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bionomics Limited has announced that its shareholders have approved the re-domiciliation of the company from Australia to the United States, converting it into a Delaware corporation under ...

ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) ("Bionomics" or the "Company") is pleased to provide the following update on the status of ...

Neuphoria Therapeutics has successfully completed the re-domiciliation of Bionomics Limited, positioning itself as the ultimate parent company, which may enhance its strategic presence in the ...

ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...

ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...